These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11797174)

  • 1. Postexposure treatment of rabies infection: can it be done without immunoglobulin?
    Wilde H; Khawplod P; Hemachudha T; Sitprija V
    Clin Infect Dis; 2002 Feb; 34(4):477-80. PubMed ID: 11797174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
    Goudsmit J; Marissen WE; Weldon WC; Niezgoda M; Hanlon CA; Rice AB; Kruif Jd; Dietzschold B; Bakker AB; Rupprecht CE
    J Infect Dis; 2006 Mar; 193(6):796-801. PubMed ID: 16479514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit anti-rabies immunoglobulins production and evaluation.
    Liu X; Liu Q; Feng X; Tang Q; Wang Z; Li S; Feng Z; Zhu J; Guan X
    Trop Biomed; 2011 Apr; 28(1):138-48. PubMed ID: 21602780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabies update for travel medicine advisors.
    Wilde H; Briggs DJ; Meslin FX; Hemachudha T; Sitprija V
    Clin Infect Dis; 2003 Jul; 37(1):96-100. PubMed ID: 12830414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.
    Lang J; Simanjuntak GH; Soerjosembodo S; Koesharyono C
    Bull World Health Organ; 1998; 76(5):491-5. PubMed ID: 9868840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment.
    Wasi C; Chaiprasithikul P; Auewarakul P; Puthavathana P; Thongcharoen P; Trishnananda M
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):461-6. PubMed ID: 8160053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, purification and characterization of a human single-chain Fv antibody fragment fused with the Fc of an IgG1 targeting a rabies antigen in Pichia pastoris.
    Wang DD; Su MM; Sun Y; Huang SL; Wang J; Yan WQ
    Protein Expr Purif; 2012 Nov; 86(1):75-81. PubMed ID: 22982755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies.
    Prosniak M; Faber M; Hanlon CA; Rupprecht CE; Hooper DC; Dietzschold B
    J Infect Dis; 2003 Jul; 188(1):53-6. PubMed ID: 12825170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity.
    Bakker AB; Python C; Kissling CJ; Pandya P; Marissen WE; Brink MF; Lagerwerf F; Worst S; van Corven E; Kostense S; Hartmann K; Weverling GJ; Uytdehaag F; Herzog C; Briggs DJ; Rupprecht CE; Grimaldi R; Goudsmit J
    Vaccine; 2008 Nov; 26(47):5922-7. PubMed ID: 18804136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to purified chick embryo cell vaccine in equines for production of equine rabies immune globulin.
    Goel SK; Sharma S; Singh US
    Biologicals; 2003 Dec; 31(4):233-6. PubMed ID: 14624792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus.
    Lodmell DL; Ewalt LC; Parnell MJ; Rupprecht CE; Hanlon CA
    Vaccine; 2006 Jan; 24(4):412-6. PubMed ID: 16153757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies control in South and Southeast Asia.
    Wilde H; Khawplod P; Khamoltham T; Hemachudha T; Tepsumethanon V; Lumlerdacha B; Mitmoonpitak C; Sitprija V
    Vaccine; 2005 Mar; 23(17-18):2284-9. PubMed ID: 15755612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the skin sensitivity test required for administering equine rabies immunoglobulin?
    Sudarshan MK; Ashwath Narayana DH; Ravish HS
    Natl Med J India; 2011; 24(2):80-2. PubMed ID: 21668049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine rabies immunoglobulin: a study on its clinical safety.
    Satpathy DM; Sahu T; Behera TR
    J Indian Med Assoc; 2005 Apr; 103(4):238, 241-2. PubMed ID: 16173435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine.
    Liu Y; Zhang S; Ma G; Zhang F; Hu R
    Vaccine; 2008 Oct; 26(42):5368-72. PubMed ID: 18721839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine rabies immune globulin: a product with an undeserved poor reputation.
    Wilde H; Chutivongse S
    Am J Trop Med Hyg; 1990 Feb; 42(2):175-8. PubMed ID: 2316787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview, prevention, and treatment of rabies.
    Nigg AJ; Walker PL
    Pharmacotherapy; 2009 Oct; 29(10):1182-95. PubMed ID: 19792992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a virus neutralization potency test in BHK-21 cells for rabies immunoglobulins in a two-center study.
    de Moura WC; Gallina NM; Fuches RM; Romijn PC; Leite JP
    J Virol Methods; 2008 Dec; 154(1-2):7-13. PubMed ID: 18851992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.